<DOC>
	<DOC>NCT00164008</DOC>
	<brief_summary>The purpose of this trial is to see whether zoledronic acid is better than pamidronate to treat low bone density in heart and lung transplant patients.</brief_summary>
	<brief_title>Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases, Metabolic</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>reduced bone density as indicated by a bone density T score &lt;1.in either the lumbar spine or femoral neck have undergone or are on the waiting list for heart or lung transplantation are receiving adequate calcium and vitamin D therapy have provided written informed consent prior to participation in the trial untreated hypogonadism, hypothyroidism or hyperthyroidism acute or major organ rejection or intercurrent illness pregnancy or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>